The Motley Fool

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
InfoQ

MIT's Recursive Language Models Improve Performance on Long-Context Tasks

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...
The New York Times

The Oura Ring 4 Can Tell You How You Slept or Predict a Cold. Is It Worth It?

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Ayanna Redwood-Crawford Ayanna Redwood-Crawford is a writer covering beauty ...